$5.16
N/A
Last update: Nov 10, 10:17 AM
Aurora Cannabis Inc
ACBNASDAQ
Aurora Cannabis rose 10.5% from $4.67 to $5.16, ahead of the S&P 500's +10.5%. Its worst day was Apr 23 (−13.7%), and its low came Jul 16 at $2.58.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Aurora Cannabis closed at its highest level of the year, 19.3% above where the year started.
+0.7% · S&P 500 −1.1%
EPS of $0.02 missed the $0.19 estimate on $67.6M revenue (est. $65.9M).
Story events cover the past 12 months · Times ET
−7.6% · S&P 500 −0.5%
Aurora Cannabis shares fell 13.7%, while the S&P 500 fell 0.4%.
−13.7%, the year's worst day · S&P 500 −0.4%
EPS of $-0.35 missed the $-0.07 estimate on $61.8M revenue (est. $55.3M).
−6.4% · S&P 500 +1.7%
Aurora Cannabis closed at its lowest level of the year, 44.8% below where the year started.
−3.0% · S&P 500 −0.5%
EPS of $-0.05 beat the $-0.13 estimate on $48.8M revenue (est. $50.5M).
+3.6% · S&P 500 −0.2%
Aurora Cannabis shares rose 13.8%, while the S&P 500 rose 0.7%.
+13.8% · S&P 500 +0.7%
EPS of $-0.22 missed the $-0.03 estimate on $61.5M revenue (est. $52.5M).
−1.0% · S&P 500 −4.4%
Where it ended: a close of $5.16 on Nov 9, 2026. Up next: Q3 2027 earnings on Feb 3, 2027 (EPS est. $-0.02, revenue est. $55.4M).
Nothing in the past 12 months.
All ACB analyst actionsNothing in the past 12 months.
All ACB dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ACB and SPY from Benzinga historical bars. Not investment advice.
